NCT02097147

Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo

A Multi-Center, Randomized, Double-Blind, Parallel-Group Study Evaluating The Sexual Functioning of Healthy Adults After Receiving Multiple-Dose Regimens of Vilazodone, Paroxetine, or Placebo

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 202 (actual)
• Sponsor: Forest Laboratories · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

To compare the effects of vilazodone, paroxetine and placebo on sexual function in sexually active healthy adults.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Vilazodone 20 mg	Oral administration, once per day.
DRUG	Vilazodone 40 mg	Oral administration, once per day.
DRUG	Paroxetine 20 mg	Oral administration, once per day.
DRUG	Placebo	Oral administration, once per day.

Timeline

• Start date: 2014-03-01
• Primary completion: 2014-09-01
• Completion: 2014-11-01
• First posted: 2014-03-26
• Last updated: 2015-02-12

Locations

4 sites across 1 country: United States